Corrigendum to "Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies" [J hepatol 67 (2017) 999-1008].
Sign Up to like & getrecommendations! Published in 2018 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2018.07.015
Abstract: Hepatic Oncology, BCLC Hospital Clínic Barcelona, IDIBAPS, University of Barcelona CIBERehd, Barcelona, Spain; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA; Mount Sinai Liver Cancer Program, Icahn School… read more here.
Keywords: sorafenib benefit; prognostic factors; corrigendum prognostic; oncology ... See more keywords
Corrigendum to “The Prognostic Significance of Tumor Deposit Count for Colorectal Cancer Patients after Radical Surgery”
Sign Up to like & getrecommendations! Published in 2020 at "Gastroenterology Research and Practice"
DOI: 10.1155/2020/1848252
Abstract: [This corrects the article DOI: 10.1155/2020/2052561.]. read more here.
Keywords: tumor deposit; corrigendum prognostic; count colorectal; significance tumor ... See more keywords
Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.723153
Abstract: [This corrects the article DOI: 10.3389/fphar.2020.585255.]. read more here.
Keywords: model based; related long; immune related; prognostic model ... See more keywords